GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Weight-loss drugs' hit to UK grocery spending tops £1 billion, Worldpanel says - Finance news and analysis from Global Banking & Finance Review
Finance

Weight-loss drugs' hit to UK grocery spending tops £1 billion, Worldpanel says

Published by Global Banking & Finance Review

Posted on November 19, 2026

2 min read

· Last updated: November 19, 2026

Add as preferred source on Google

Weight-Loss Drugs Lead to Over £1 Billion Drop in UK Grocery Spending

Impact of GLP-1 Drugs on UK Grocery Market

LONDON, Nov 19 (Reuters) - The impact of weight-loss drugs on UK grocery spending has surpassed £1 billion ($1.32 billion), as new pill formats and rising uptake among men accelerate their use, researcher Worldpanel by Numerator said on Thursday.

Key Findings from Worldpanel by Numerator

Spending Reductions Among GLP-1 Users

• UK households with at least one GLP‑1 user spent more than £1 billion less on groceries than expected in the year after adoption compared with households without a GLP-1 user, Worldpanel said

• The £1 billion figure of displaced spending from Britain's grocery market is equivalent to £389 a year displaced from each user households' shopping baskets.

• Spending on alcohol and crisps among users has fallen 15% more than in non-user households

Trends in GLP-1 Drug Adoption

• The proportion of British households with a user of GLP-1 drugs, such as Eli Lilly's Mounjaro or Novo Nordisk's Wegovy, has risen from 6.3% in February this year to 8.5% in August

• Growth is accelerating. In the six-month period, user numbers of GLP-1 injections and pills rose almost as much as they did in the whole of the previous year

• Despite regulatory approval only coming in June, pills, account for 11.2% of UK GLP-1 users

• Men are also driving growth, making up 32% of users, up from 23% in February

Future Projections

• Worldpanel said its estimates suggested that GLP-1 usage was set to surpass 10% of British households in 2027

Changes in Consumer Behavior

• In contrast, easy, portion-controlled options are gaining ground. Volume sales of frozen ready meals have risen 30% among users

About the Research

• Worldpanel by Numerator is a global consumer data company. Its survey data of what British households buy drew from a total sample of 9,629

($1 = 0.7578 pounds)

(Reporting by James Davey)

Key Takeaways

  • Households with a GLP‑1 user spent over £1 billion less on groceries in the year after adoption, averaging a £389 annual reduction per user household, versus non‑user households. (aa.com.tr)
  • GLP‑1 drug usage among UK households rose from 6.3% in February to 8.5% in August, with rapid growth in both injections and pills—even though pill approval only arrived in June; male user share climbed from 23% to 32%. citeturn862932news0
  • Spending on alcohol and crisps declined by 15% more in user households, while volume sales of frozen ready meals jumped 30%; Worldpanel projects GLP‑1 adoption will surpass 10% of UK households in 2027. citeturn862932news0
  • Previous mid‑2026 data showed a £780 million drop in grocery spending and a £418 annual per‑household reduction, with three‑quarters of users cutting chocolate and crisps and increasing purchases of mouthwash and chewing gum due to side effects. (theguardian.com)

References

Frequently Asked Questions

How much has UK grocery spending fallen due to weight-loss drugs?
UK grocery spending has dropped by over £1 billion in the year after households began using GLP-1 weight-loss drugs.
Which weight-loss drugs are mentioned in the report?
The report highlights GLP-1 drugs including Eli Lilly's Mounjaro and Novo Nordisk's Wegovy.
What share of UK households now use GLP-1 weight-loss drugs?
As of August, 8.5% of British households have a user of GLP-1 drugs, up from 6.3% in February.
How are spending habits changing among GLP-1 users?
Spending on alcohol and crisps has fallen, while sales of frozen ready meals have risen by 30% among GLP-1 users.
Who is driving the growth in GLP-1 weight-loss drug usage?
Men are increasingly driving growth, now making up 32% of UK GLP-1 users, up from 23% in February.

Tags

Related Articles

More from Finance

Explore more articles in the Finance category